Laboratory Animal Models, 3D Cultures and Organoids: Global Markets
August 10, 2022
BCC Research
198
PDF
Laboratory Animal Models, 3D Cultures and Organoids: Global Markets
Abstract Report Scope:
The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.
Report Includes:
- 26 data tables and 28 additional tables - An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry - Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027 - Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market - Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region - Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc. - Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds - Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry - Review of selected patents and patent applications on organoids, and emerging developments in the global market - Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues - Descriptive company profiles of the leading Organoids market players, including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB), and STEMCELL Technologies Inc.
Content Table of Contents
Chapter 1 Introduction Background Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in This Update? Information Sources and Methodology Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Animal Model Market Technology Background Methods of Animal Model and 3D Cell Culture Modification Physical and Chemical Mutations Targeted Mutations Other Technologies Laboratory Animal Models Market Definition Animal Model Lines Common Species of Laboratory Animals Chapter 4 Impact of COVID-19 on the Global Market for Organoids Overview Impact of COVID-19 on Organoids Conclusion Chapter 5 Market Dynamics Market Drivers Increasing Emphasis on Developing Alternative Approaches to Animal Testing Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth Increasing Adoption of the Organoid Technology for Wide Range of Applications Market Restraints Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells Concerns Associated with the Integration of Organoids into Current Workflows Market Opportunities Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine Chapter 6 3D Cell Technology Background 3D Cell Cultures Spheroids 2D Cultures vs. 2.5D Cultures vs. 3D Cultures Scaffold-Based and Scaffold-Free 3D Cell Cultures Scaffold-Free 3D Cell Cultures Scaffold-Based 3D Cell Cultures Tissue Engineering and Bioprinting 3D Bioprinting Technology Types of Bioprinting Methods Microfluidic Organ-on-Chip Platforms Types of Organ-on-Chip Devices Chapter 7 Market Breakdown by Organ Type Global Market for Organoids, by Organ Type Intestine Market Size and Forecast Liver Market Size and Forecast Stomach Market Size and Forecast Pancreas Market Size and Forecast Lung (Pulmonary) Market Size and Forecast Kidney Market Size and Forecast Others Cardiac Organoids Cancer Organoids Market Size and Forecast Chapter 8 Market Breakdown by Application Global Market for Organoids, by Application Developmental Biology Market Size and Forecast Drug Discovery and Personalized Medicine Market Size and Forecast Regenerative Medicine Market Size and Forecast Pathology of Infectious Disease Market Size and Forecast Drug Toxicity and Efficacy Testing Market Size and Forecast Chapter 9 Market Breakdown by Region Global Market for Organoids, by Region North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe Asia-Pacific China Japan Australia India Rest of Asia-Pacific Rest of the World Market Size and Forecast Chapter 10 Patent Review/New Developments Chapter 11 Analysis of Market Opportunities Market Opportunities: Animal Models Market Opportunities: 3D Cell Culture Segment Organs-on-Chip Organoids Bioprinting Advantages and Disadvantages of 3D Cell Cultures and Animal Models Animal Models 3D Cell Cultures in General Organoids Organs-on-Chip Chapter 12 Competitive Landscape Chapter 13 Profiles of Companies and Important Institutions Animal Model Companies ALPHA GENESIS INC. CHARLES RIVER LABORATORIES INTERNATIONAL INC. ENVIGO GENOWAY S.A. LABCORP DRUG DEVELOPMENT (COVANCE INC.) THE JACKSON LABORATORY JANVIER LABS OAK HILL GENETICS PRIMGEN TACONIC BIOSCIENCES TRANSGENIC INC. TRANSPOSAGEN BIOPHARMACEUTICALS INC. Bioprinting and Regenerative Medicine Companies ALLEVI ASPECT BIOSYSTEMS LTD. BIOINK SOLUTIONS INC. CELLINK INC. COLLPLANT HOLDINGS LTD. EAST RIVER BIOSOLUTIONS/XYLYX BIO EPIBONE MATTEK CORP. NANO 3D BIOSCIENCES INC. ORGANOVO HOLDINGS INC. PEPGEL LLC REGENHU TEVIDO BIODEVICES INC. TISSUSE GMBH Organ-on-Chip Companies AXOSIM EMULATE INC. KIRKSTALL LTD. MICRONIT MICROTECHNOLOGIES MIMETAS TARA BIOSYSTEMS INC. Organoid Companies 3DNAMICS INC. CELLESCE CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER CROWN BIOSCIENCE CORNING INC. DEFINIGEN HUBRECHT ORGANOID TECHNOLOGY (HUB) MERCK KGAA R&D SYSTEMS INC. STEMCELL TECHNOLOGIES INC. THERMO FISHER SCIENTIFIC TREVIGEN INC. (BIO-TECHNE) Other 3D Cell Culture Companies 3D BIOTEK LLC ADVANCED BIOMATRIX INC. HORIZON DISCOVERY LTD. INSPHERO INC. PROMOCELL GMBH REPROCELL INC. SYNTHECON INC.
List of Tables Summary Table : Global Market for Organoids, by Organ Type, Through 2027 Table A : Comparison of Changes in the Segmentation of the Old and New Version of the Report Table 1 : Global Market for Organoids, by Organ Type, Through 2027 Table 2 : Global Market for Intestine Organoids, by Region, Through 2027 Table 3 : Global Market for Liver Organoids, by Region, Through 2027 Table 4 : Global Market for Stomach Organoids, by Region, Through 2027 Table 5 : Global Market for Pancreatic Organoids, by Region, Through 2027 Table 6 : Global Market for Lung Organoids, by Region, Through 2027 Table 7 : Global Market for Kidney Organoids, by Region, Through 2027 Table 8 : Global Market for Other Organoids Segment, by Region, Through 2027 Table 9 : Global Market for Organoids, by Application, Through 2027 Table 10 : Global Market for Organoids in Developmental Biology, by Region, Through 2027 Table 11 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, Through 2027 Table 12 : Global Market for Organoids in Regenerative Medicine, by Region, Through 2027 Table 13 : Global Market for Organoids in Pathology of Infectious Disease, by Region, Through 2027 Table 14 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, Through 2027 Table 15 : Global Market for Organoids, by Region, Through 2027 Table 16 : North American Market for Organoids, by Organ Type, Through 2027 Table 17 : North American Market for Organoids, by Country, Through 2027 Table 18 : European Market for Organoids, by Organ Type, Through 2027 Table 19 : European Market for Organoids, by Country, Through 2027 Table 20 : Asia-Pacific Market for Organoids, by Organ Type, Through 2027 Table 21 : Asia-Pacific Market for Organoids, by Country, Through 2027 Table 22 : Rest of the World Market for Organoids, by Organ Type, Through 2027 Table 23 : Review of Selected Patents and Patent Applications on Organoids, 2008–2021 Table 24 : Global Number of Transplanted Organs, by Country, 2017 Table 25 : Global Organoids Vendors, by Ranking, 2021 Table 26 : Alpha Genesis Inc.: Recent Developments, 2017–2020 Table 27 : Charles River Laboratories International Inc.: Recent Developments, 2020–2022 Table 28 : Envigo: Types of Laboratory Animals Table 29 : Envigo: Recent Developments, 2021–2022 Table 30 : GenOway: Recent Developments, 2018–2022 Table 31 : LabCorp Drug Development: Recent Developments, 2022 Table 32 : The Jackson Laboratory: Recent Developments, 2021 Table 33 : Janvier Labs: Segments Table 34 : Taconic Biosciences: Segments Table 35 : Transgenic Inc.: Segments Table 36 : Transgenic Inc.: Company Financials, 2014–2018 Table 37 : Transposagen Biopharmaceuticals Inc.: Segments Table 38 : Organovo: Expenses on R&D, 2016–2020 Table 39 : Cellesce.: Recent Developments, 2018–2022 Table 40 : Cincinnati Children's Hospital Medical Center: Recent Developments, 2021 Table 41 : Crown Bioscience: Recent Developments, 2021–2022 Table 42 : Corning Inc.: Recent Developments, 2018–2021 Table 43 : DefiniGEN: Recent Developments, 2020–2021 Table 44 : Hubrecht Organoid Technology (HUB): Recent Developments, 2017–2021 Table 45 : Merck KGaA: Products Offered Table 46 : Merck KGaA: Recent Developments, 2020–2021 Table 47 : STEMCELL Technologies Inc.: Recent Developments, 2018–2022 Table 48 : Thermo Fisher Scientific: Products Offered Table 49 : Thermo Fisher Scientific: Recent Developments Table 50 : 3D Biotek LLC: Segments Table 51 : In Sphero Inc.: Segments Table 52 : Reprocell Inc.: Acquisitions
The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.
Report Includes:
- 26 data tables and 28 additional tables - An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry - Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027 - Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market - Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region - Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc. - Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds - Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry - Review of selected patents and patent applications on organoids, and emerging developments in the global market - Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues - Descriptive company profiles of the leading Organoids market players, including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB), and STEMCELL Technologies Inc.
Table of Contents
Chapter 1 Introduction Background Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in This Update? Information Sources and Methodology Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Animal Model Market Technology Background Methods of Animal Model and 3D Cell Culture Modification Physical and Chemical Mutations Targeted Mutations Other Technologies Laboratory Animal Models Market Definition Animal Model Lines Common Species of Laboratory Animals Chapter 4 Impact of COVID-19 on the Global Market for Organoids Overview Impact of COVID-19 on Organoids Conclusion Chapter 5 Market Dynamics Market Drivers Increasing Emphasis on Developing Alternative Approaches to Animal Testing Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth Increasing Adoption of the Organoid Technology for Wide Range of Applications Market Restraints Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells Concerns Associated with the Integration of Organoids into Current Workflows Market Opportunities Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine Chapter 6 3D Cell Technology Background 3D Cell Cultures Spheroids 2D Cultures vs. 2.5D Cultures vs. 3D Cultures Scaffold-Based and Scaffold-Free 3D Cell Cultures Scaffold-Free 3D Cell Cultures Scaffold-Based 3D Cell Cultures Tissue Engineering and Bioprinting 3D Bioprinting Technology Types of Bioprinting Methods Microfluidic Organ-on-Chip Platforms Types of Organ-on-Chip Devices Chapter 7 Market Breakdown by Organ Type Global Market for Organoids, by Organ Type Intestine Market Size and Forecast Liver Market Size and Forecast Stomach Market Size and Forecast Pancreas Market Size and Forecast Lung (Pulmonary) Market Size and Forecast Kidney Market Size and Forecast Others Cardiac Organoids Cancer Organoids Market Size and Forecast Chapter 8 Market Breakdown by Application Global Market for Organoids, by Application Developmental Biology Market Size and Forecast Drug Discovery and Personalized Medicine Market Size and Forecast Regenerative Medicine Market Size and Forecast Pathology of Infectious Disease Market Size and Forecast Drug Toxicity and Efficacy Testing Market Size and Forecast Chapter 9 Market Breakdown by Region Global Market for Organoids, by Region North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe Asia-Pacific China Japan Australia India Rest of Asia-Pacific Rest of the World Market Size and Forecast Chapter 10 Patent Review/New Developments Chapter 11 Analysis of Market Opportunities Market Opportunities: Animal Models Market Opportunities: 3D Cell Culture Segment Organs-on-Chip Organoids Bioprinting Advantages and Disadvantages of 3D Cell Cultures and Animal Models Animal Models 3D Cell Cultures in General Organoids Organs-on-Chip Chapter 12 Competitive Landscape Chapter 13 Profiles of Companies and Important Institutions Animal Model Companies ALPHA GENESIS INC. CHARLES RIVER LABORATORIES INTERNATIONAL INC. ENVIGO GENOWAY S.A. LABCORP DRUG DEVELOPMENT (COVANCE INC.) THE JACKSON LABORATORY JANVIER LABS OAK HILL GENETICS PRIMGEN TACONIC BIOSCIENCES TRANSGENIC INC. TRANSPOSAGEN BIOPHARMACEUTICALS INC. Bioprinting and Regenerative Medicine Companies ALLEVI ASPECT BIOSYSTEMS LTD. BIOINK SOLUTIONS INC. CELLINK INC. COLLPLANT HOLDINGS LTD. EAST RIVER BIOSOLUTIONS/XYLYX BIO EPIBONE MATTEK CORP. NANO 3D BIOSCIENCES INC. ORGANOVO HOLDINGS INC. PEPGEL LLC REGENHU TEVIDO BIODEVICES INC. TISSUSE GMBH Organ-on-Chip Companies AXOSIM EMULATE INC. KIRKSTALL LTD. MICRONIT MICROTECHNOLOGIES MIMETAS TARA BIOSYSTEMS INC. Organoid Companies 3DNAMICS INC. CELLESCE CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER CROWN BIOSCIENCE CORNING INC. DEFINIGEN HUBRECHT ORGANOID TECHNOLOGY (HUB) MERCK KGAA R&D SYSTEMS INC. STEMCELL TECHNOLOGIES INC. THERMO FISHER SCIENTIFIC TREVIGEN INC. (BIO-TECHNE) Other 3D Cell Culture Companies 3D BIOTEK LLC ADVANCED BIOMATRIX INC. HORIZON DISCOVERY LTD. INSPHERO INC. PROMOCELL GMBH REPROCELL INC. SYNTHECON INC.
List of Tables Summary Table : Global Market for Organoids, by Organ Type, Through 2027 Table A : Comparison of Changes in the Segmentation of the Old and New Version of the Report Table 1 : Global Market for Organoids, by Organ Type, Through 2027 Table 2 : Global Market for Intestine Organoids, by Region, Through 2027 Table 3 : Global Market for Liver Organoids, by Region, Through 2027 Table 4 : Global Market for Stomach Organoids, by Region, Through 2027 Table 5 : Global Market for Pancreatic Organoids, by Region, Through 2027 Table 6 : Global Market for Lung Organoids, by Region, Through 2027 Table 7 : Global Market for Kidney Organoids, by Region, Through 2027 Table 8 : Global Market for Other Organoids Segment, by Region, Through 2027 Table 9 : Global Market for Organoids, by Application, Through 2027 Table 10 : Global Market for Organoids in Developmental Biology, by Region, Through 2027 Table 11 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, Through 2027 Table 12 : Global Market for Organoids in Regenerative Medicine, by Region, Through 2027 Table 13 : Global Market for Organoids in Pathology of Infectious Disease, by Region, Through 2027 Table 14 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, Through 2027 Table 15 : Global Market for Organoids, by Region, Through 2027 Table 16 : North American Market for Organoids, by Organ Type, Through 2027 Table 17 : North American Market for Organoids, by Country, Through 2027 Table 18 : European Market for Organoids, by Organ Type, Through 2027 Table 19 : European Market for Organoids, by Country, Through 2027 Table 20 : Asia-Pacific Market for Organoids, by Organ Type, Through 2027 Table 21 : Asia-Pacific Market for Organoids, by Country, Through 2027 Table 22 : Rest of the World Market for Organoids, by Organ Type, Through 2027 Table 23 : Review of Selected Patents and Patent Applications on Organoids, 2008–2021 Table 24 : Global Number of Transplanted Organs, by Country, 2017 Table 25 : Global Organoids Vendors, by Ranking, 2021 Table 26 : Alpha Genesis Inc.: Recent Developments, 2017–2020 Table 27 : Charles River Laboratories International Inc.: Recent Developments, 2020–2022 Table 28 : Envigo: Types of Laboratory Animals Table 29 : Envigo: Recent Developments, 2021–2022 Table 30 : GenOway: Recent Developments, 2018–2022 Table 31 : LabCorp Drug Development: Recent Developments, 2022 Table 32 : The Jackson Laboratory: Recent Developments, 2021 Table 33 : Janvier Labs: Segments Table 34 : Taconic Biosciences: Segments Table 35 : Transgenic Inc.: Segments Table 36 : Transgenic Inc.: Company Financials, 2014–2018 Table 37 : Transposagen Biopharmaceuticals Inc.: Segments Table 38 : Organovo: Expenses on R&D, 2016–2020 Table 39 : Cellesce.: Recent Developments, 2018–2022 Table 40 : Cincinnati Children's Hospital Medical Center: Recent Developments, 2021 Table 41 : Crown Bioscience: Recent Developments, 2021–2022 Table 42 : Corning Inc.: Recent Developments, 2018–2021 Table 43 : DefiniGEN: Recent Developments, 2020–2021 Table 44 : Hubrecht Organoid Technology (HUB): Recent Developments, 2017–2021 Table 45 : Merck KGaA: Products Offered Table 46 : Merck KGaA: Recent Developments, 2020–2021 Table 47 : STEMCELL Technologies Inc.: Recent Developments, 2018–2022 Table 48 : Thermo Fisher Scientific: Products Offered Table 49 : Thermo Fisher Scientific: Recent Developments Table 50 : 3D Biotek LLC: Segments Table 51 : In Sphero Inc.: Segments Table 52 : Reprocell Inc.: Acquisitions